Get the latest tech news
Profluent, spurred by Salesforce research and backed by Jeff Dean, uses AI to discover medicines
Last year, Salesforce, the company best known for its cloud sales support software (and Slack), spearheaded a project called ProGen to design proteins
In an interview with TechCrunch, Madani describes Profluent’s mission as “reversing the drug development paradigm”: starting with patient and therapeutic needs and working backwards to create “custom-fit” treatments solution. Proteins — chains of bonded-together amino acids that the body uses for various purposes, from making hormones to repairing bone and muscle tissue — can be treated like words in a paragraph, Madani discovered. And DeepMind, Google’s AI research lab, has a system called AlphaFold that predicts complete protein structures, achieving speed and accuracy far surpassing older, less complex algorithmic methods.
Or read this on TechCrunch